IgG1 plasmacytosis in interleukin 6 transgenic mice.
AUTOR(ES)
Suematsu, S
RESUMO
Interleukin 6 (IL-6) has been suggested to be involved in the pathogenesis of polyclonal and monoclonal plasma cell abnormalities. To address this possibility, transgenic mice carrying the human IL-6 genomic gene fused with a human immunoglobulin heavy chain enhancer were generated. High concentrations of human IL-6 and polyclonal increase in IgG1 (120- to 400-fold) in sera of all transgenic mice were observed. A massive plasmacytosis in thymus, lymph node, and spleen and an infiltration of plasma cells in lung, liver, and kidney were observed. However, the plasma cells were not transplantable to syngeneic mice and were found not to contain chromosomal aberrations including c-myc gene rearrangements. The evidence indicates that deregulated gene expression of IL-6 can trigger polyclonal plasmacytosis but cannot induce plasmacytoma. It is suggested that additional genetic changes may be required for the generation of plasma cell neoplasia. Other interesting findings in these transgenic mice were the development of mesangio-proliferative glomerulonephritis and an increase in megakaryocytes in bone marrow.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=298102Documentos Relacionados
- Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice.
- Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation.
- Avaliação das subclasses IgG1 e IgG3 na doença hemolítica perinatal
- Detection of IgG1 and IgG4 subtypes reactive against potato apyrase in schistosomiasis patients
- Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation.